Cathryn Shaw Reid
About Cathryn Shaw Reid
Cathryn Shaw Reid is the Vice President of Global DS Biologics Operations at Bristol Myers Squibb, with a strong background in pharmaceutical and biotechnology industries, including extensive experience at Amgen and Merck.
Title
Cathryn Shaw Reid is currently holding the position of Vice President, Global DS Biologics Operations at Bristol Myers Squibb.
Current Company
Cathryn Shaw Reid is currently working at Bristol Myers Squibb, where she is responsible for the worldwide Biologics drug substance manufacturing network strategy and operations.
Previous Roles at Amgen
Cathryn Shaw Reid held multiple roles at Amgen, including Executive Director, Manufacturing (2018-2020), Executive Director, Process Development (2017-2018) in Thousand Oaks, California, Executive Director, Operations Strategic Planning and Risk (2015-2017), Director, Manufacturing (2010-2015) in Thousand Oaks, CA and Puerto Rico, and Director, Global Operations (2008-2010). Before these roles, she was a Principal Scientist at Amgen from 2004 to 2008.
Previous Roles at Merck and Harvard Medical School
At Merck, Cathryn Reid served as a Research Fellow from 1999 to 2004 in West Point, PA. She also worked at Harvard Medical School as a Post-Doctoral Associate from 1997 to 1999.
Education and Expertise
Cathryn Shaw Reid holds a Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology. Additionally, she achieved a B.S. and B.A. in Chemical Engineering and Liberal Arts from Columbia University in the City of New York.
Skills and Leadership
Cathryn Shaw Reid is skilled in cross-functional global team leadership, discovery and innovation, lean GMP production, strategic planning, and transformational change management. She has a strong foundation in technical and analytical capabilities, with passion for developing organizations and leaders, building teams, and motivating individuals to deliver superior performance.